Question is on our pharma part of the business; you mentioned that there is a high inventories with the customer. Can you just explain it a little bit because we understood so far that the higher inventories were the only problem in the ag ro chemicals. So, just in pharma, please, if you can explain how long it may continue to impact our revenues?
It was only related to one product with one customer.
Sir, first question is on Fluoropolymer, I mean if you refer to your last concall , you mentioned that this year FY25, you see a significant growth in Fluoropolymers which will be primarily led by volume and almost taking us to previous year profitability. Sir, do you see that kind of pickup in Fluoropolymer has already happened? And ov erall, for this year, we can achieve those numbers which you were guiding for last quarter?
Questions on the approvals, which you mentioned in the PVDF for the battery grades, those you give answered the previous question, Sir, if it will be possible for you to share some more timelines related to that in terms of where we are in approval cycle? I am sure that you are dealing with the multiple customers, but what kind of volume do you think that your customers are having started giving you indication that we can build up for the current year and for the next year more in PVDF high grade battery for the battery usage and also if you can give some sense on a like LiPF and PFA?